Imaging and Molecular Mechanisms of Alzheimer's Disease: A Review

被引:46
|
作者
Femminella, Grazia Daniela [1 ]
Thayanandan, Tony [2 ]
Calsolaro, Valeria [1 ]
Komici, Klara [3 ]
Rengo, Giuseppe [4 ,5 ]
Corbi, Graziamaria [3 ]
Ferrara, Nicola [4 ,5 ]
机构
[1] Imperial Coll London, Neurol Imaging Unit, London W12 0NN, England
[2] Imperial Coll London, Charing Cross Hosp, Imperial Memory Unit, London W6 8RF, England
[3] Univ Molise, Dept Med & Hlth Sci, I-86100 Campobasso, Italy
[4] Federico II Univ Naples, Dept Translat Med Sci, I-80131 Naples, Italy
[5] IRCCS, Ist Clin Sci Maugeri SPA, Soc Benefit, I-82037 Telese Terme, Italy
关键词
Alzheimer's disease; positron emission tomography (PET); magnetic resonance imaging (MRI); POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; BLOOD-BRAIN-BARRIER; PITTSBURGH COMPOUND B; PERIPHERAL BENZODIAZEPINE-RECEPTOR; CEREBRAL GLUCOSE-METABOLISM; PARTIAL VOLUME CORRECTION; BETA-AMYLOID BURDEN; FLORBETAPIR F 18; IN-VIVO;
D O I
10.3390/ijms19123702
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease is the most common form of dementia and is a significant burden for affected patients, carers, and health systems. Great advances have been made in understanding its pathophysiology, to a point that we are moving from a purely clinical diagnosis to a biological one based on the use of biomarkers. Among those, imaging biomarkers are invaluable in Alzheimer's, as they provide an in vivo window to the pathological processes occurring in Alzheimer's brain. While some imaging techniques are still under evaluation in the research setting, some have reached widespread clinical use. In this review, we provide an overview of the most commonly used imaging biomarkers in Alzheimer's disease, from molecular PET imaging to structural MRI, emphasising the concept that multimodal imaging would likely prove to be the optimal tool in the future of Alzheimer's research and clinical practice.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
    Sery, Omar
    Povova, Jana
    Misek, Ivan
    Pesak, Lukas
    Janout, Vladimir
    [J]. FOLIA NEUROPATHOLOGICA, 2013, 51 (01) : 1 - 9
  • [2] MOLECULAR MECHANISMS OF ALZHEIMER'S DISEASE
    Bartoszewska, Magdalena
    [J]. POSTEPY BIOLOGII KOMORKI, 2008, 35 (03) : 333 - 350
  • [3] Molecular mechanisms in Alzheimer's disease
    Coria, F
    Rubio, I
    [J]. REVISTA DE NEUROLOGIA, 1997, 25 : S50 - S54
  • [4] Molecular mechanisms in Alzheimer's disease
    Kimura, H
    Aimi, Y
    Minnasch, P
    Yasuhara, O
    Bellier, JP
    Tooyama, I
    [J]. AGING: MORPHOLOGICAL, BIOCHEMICAL, MOLECULAR AND SOCIAL ASPECTS, 2002, 27 : 161 - 174
  • [5] ADVANCES IN THE MOLECULAR IMAGING OF ALZHEIMER'S DISEASE: NEUROBIOLOGICAL MECHANISMS OF DISEASE AND NEUROPSYCHIATRIC SYMPTOMS
    Mecca, Adam P.
    Smith, Gwenn S.
    Gatchel, Jennifer R.
    Donovan, J. Nancy
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S17 - S18
  • [6] Molecular imaging of Alzheimer's disease
    Semah, F.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2018, 42 (03): : 190 - 193
  • [7] Molecular imaging of Alzheimer's disease
    Albert Annamaria
    Borbely Katalin
    [J]. ORVOSI HETILAP, 2019, 160 (33) : 1289 - 1295
  • [8] Molecular imaging in Alzheimer's disease
    Lascola, C
    [J]. NEUROIMAGING CLINICS OF NORTH AMERICA, 2005, 15 (04) : 827 - +
  • [9] Molecular mechanisms of neurodegeneration in Alzheimer's disease
    Crews, Leslie
    Masliah, Eliezer
    [J]. HUMAN MOLECULAR GENETICS, 2010, 19 : R12 - R20
  • [10] Molecular mechanisms and genetics of Alzheimer's disease
    Oztan, Gozde
    Issever, Halim
    [J]. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (03): : 218 - 229